SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-23-000089
Filing Date
2023-02-28
Accepted
2023-02-28 08:00:53
Documents
22
Period of Report
2023-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20230228.htm   iXBRL 8-K 38069
2 EX-99.1 a20230228_4q2022earnings.htm EX-99.1 28229
6 a20230228_4q2022earnings001.jpg GRAPHIC 229752
7 a20230228_4q2022earnings002.jpg GRAPHIC 283209
8 a20230228_4q2022earnings003.jpg GRAPHIC 303470
9 a20230228_4q2022earnings004.jpg GRAPHIC 291179
10 a20230228_4q2022earnings005.jpg GRAPHIC 338612
11 a20230228_4q2022earnings006.jpg GRAPHIC 308454
12 a20230228_4q2022earnings007.jpg GRAPHIC 127167
13 a20230228_4q2022earnings008.jpg GRAPHIC 125047
14 a20230228_4q2022earnings009.jpg GRAPHIC 110487
  Complete submission text file 0001485003-23-000089.txt   3126931

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20230228.xsd EX-101.SCH 1902
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20230228_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20230228_pre.xml EX-101.PRE 13046
16 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20230228_htm.xml XML 9595
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 23678461
SIC: 2834 Pharmaceutical Preparations